Outsourcing of Deal Making Analysis

In this special feature interview, Fintan Walton talks with John Wyatt, Head of Commercial Development at PharmaVentures, about PharmaVentures' new service - PharmaDeals Research. John explains that PharmaDeals Research was launched to complement PharmaDeals Agreements in response to frequent customer requests for help with their deal-related research. These requests, John explains, were frequently from licensing executives who were too busy to carry out their own research and were looking for cost-effective information with a rapid turn-around. In particular, the service has been designed to fit between the PharmaDeals Agreements deals database, and the consultancy services offered by PharmaVentures.

They discuss the interest to date, which has ranged from small biotechs who quickly need one-off pieces of research, through to big pharma companies who are looking for retained, out-sourced analytical services. 

About John Wyatt

John Wyatt has nearly thirty years experience working within and serving the needs of the Life Science Industry. As a practicing medicinal chemist, John developed his career at the Wellcome Foundation to become Department Head of Physical Chemistry. During that time, he was responsible for a contribution to a number of patents and publications.

For the last fifteen years John has developed a diverse business career. Prior to his current position at PharmaVentures as Head of Commercial Development, he worked in a senior Business Development role for Applied Biosystems, and prior to this position as European Managing Director for Paracel, a Biotechnology business based in Pasadena, California. John has a PhD in organic chemistry and studied business at the Open University, to obtain an MBA in 2002.

 

About PharmaDeals Research

PharmaDeals Research is an analytical service offered by PharmaVentures which delivers smaller scale projects with fast turnaround times to enable clients to address key issues in time-critical situations. Because the projects are bounded and limited in scope, we are able to provide the service at lower costs than traditional consultancy projects. Therefore, PharmaDeals Research is ideally placed to support clients’ deal-making activities by providing a timely and effective service that can be easily incorporated into ongoing budgets.